AEB1102

· Aeglea Biotherapeutics

Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for AEB1102, covering 2018-10-17 to 2023-07-27. Get the full timeline:

Most recent: Clinical Trial Update: A Study of AEB1102 (Pegzilarginase) in Patients With Arginase I Deficiency [Phase 2]